CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Total Equity of Capri	Total Equity of Capri Cumulative Effect, Period of Adoption, Adjustment	Total Equity of Capri Cumulative Effect, Period of Adoption, Adjusted Balance	Ordinary Shares	Ordinary Shares Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Treasury Shares	Treasury Shares Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Non-controlling Interests	Non-controlling Interests Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Mar. 30, 2019							216,051,000	216,051,000
Beginning balance at Mar. 30, 2019	$ 2,432	$ (152)	$ 2,280	$ 2,429	$ (152)	$ 2,277	$ 0	$ 0	$ 1,011	$ 1,011	$ (3,223)	$ (3,223)	$ (66)	$ (66)	$ 4,707	$ (152)	$ 4,555	$ 3	$ 3
Beginning balance, treasury (in shares) at Mar. 30, 2019											(65,119,000)	(65,119,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(225)			(223)											(223)			(2)
Other comprehensive income (loss)	141			141									141					0
Comprehensive income (loss)	(84)			(82)														(2)
Vesting of restricted awards, net of forfeitures (in shares)							1,262,000
Exercise of employee share options (in shares)							7,000
Share based compensation expense	70			70					70
Repurchase of ordinary shares (in shares)											(2,775,000)
Repurchase of ordinary shares	(102)			(102)							$ (102)
Adjustment of redeemable non-controlling interests to redemption value	4			4					4
Ending balance (in shares) at Mar. 28, 2020							217,320,000
Ending balance at Mar. 28, 2020	2,168			2,167			$ 0		1,085		$ (3,325)		75		4,332			1
Ending balance, treasury (in shares) at Mar. 28, 2020											(67,894,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(63)			(62)											(62)			(1)
Other comprehensive income (loss)	(19)			(19)									(19)					0
Comprehensive income (loss)	(82)			(81)														(1)
Vesting of restricted awards, net of forfeitures (in shares)							1,456,000
Exercise of employee share options (in shares)							447,000
Exercise of employee share options	3			3					3
Share based compensation expense	70			70					70
Repurchase of ordinary shares (in shares)											(49,000)
Repurchase of ordinary shares	(1)			(1)							$ (1)
Other	$ (1)																	(1)
Ending balance (in shares) at Mar. 27, 2021	219,222,937						219,223,000
Ending balance at Mar. 27, 2021	$ 2,157			2,158			$ 0		1,158		$ (3,326)		56		4,270			(1)
Ending balance, treasury (in shares) at Mar. 27, 2021	(67,942,926)										(67,943,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 823			822											822			1
Other comprehensive income (loss)	137			138									138					(1)
Comprehensive income (loss)	960			960														0
Vesting of restricted awards, net of forfeitures (in shares)							2,336,000
Exercise of employee share options (in shares)							408,000
Exercise of employee share options	17			17					17
Share based compensation expense	85			85					85
Repurchase of ordinary shares (in shares)											(11,218,000)
Repurchase of ordinary shares	$ (661)			(661)							$ (661)
Ending balance (in shares) at Apr. 02, 2022	221,967,599						221,967,000
Ending balance at Apr. 02, 2022	$ 2,558			$ 2,559			$ 0		$ 1,260		$ (3,987)		$ 194		$ 5,092			$ (1)
Ending balance, treasury (in shares) at Apr. 02, 2022	(79,161,330)										(79,161,000)